NCT06813001Not yet recruiting
ACT-Based Nursing Intervention for Ovarian Cancer Patients: A Pilot Study
Development of ACT (Acceptance and Commitment Therapy)-Based Nurse-led Intervention for Ovarian Cancer Patients
Source: ClinicalTrials.gov · Last updated 6 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this study is to evaluate the feasiblity and effectiveness of an Acceptance and Commitment Therapy (ACT)-based nursing intervention aimed at managing psychological flexibility, distress, anxiety, depression, fear of cancer recurrence/progression, quality of life, and symptoms. Patients will participate in a single online session with a nurse, followed by a daily self-monitoring survey online for one week. Data will be collected at baseline (prior to the ACT session), on day 8 (after one week of self-monitoring), and at 5 weeks. Primary outcome is psychological flexibility.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- First submitted
- 2 Feb 2025
- Start date
- Feb 2025
- Primary completion date
- Jun 2025
- Lead sponsor
- Yonsei University
- Diseases
- Ovarian cancer
- NCT number
- NCT06813001
What you commit to
- Study type: Interventional
- Planned participants: 25
- From Feb 2025 to the primary completion date, Jun 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with cognitive problems such as dementia or psychiatric problems such as major depression or generalized anxiety, or who are actively receiving treatment for any of these conditions.
Other illness
- Patients with history of cancer recurrence.
Who the study is looking for
- adult (19 ≤ age ≤ 75).
- ovarian cancer patients with FIGO stage 2-3.
- Those who have completed first-line chemotherapy for ovarian cancer (excluding maintenance therapy) within the past 2 years.
Age in the registry: 19 years to 75 years · Sex: Female · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.